Replies to post #80422 on Biotech Values

[DewDiligence]

ARYX – If you’re expecting that some third party is going to sub-license the program from PG, I think you’re dreaming.

[mcbio]

Re: ARYX/P&G

So I guess you also read the contract between PRoctor and Gamble with ARYX and you know that if they terminated the trials it wouldn't revert back to ARYX automatically.

Can you clarify what you're saying here? I thought during the recent Jefferies webcast that management stated that ARYX had taken the drug back from P&G and had begun, or was about to begin, discussions with potential new partners for the drug.